Drug Survival of Adalimumab and Infliximab in Hidradenitis Suppurativa
International Journal of Dermatology · 2026-09 · 65 (9) · 1907-1909
DOI: 10.1111/ijd.70455 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 13.05.2026. Verfasst von Raslina Shrestha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Hanoi Medical University, Hanoi, Vietnam.
- National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Raslina Shrestha, Giang H Nguyen
Zitieren
APA
Shrestha, R., Tran, H. T. T., Van, D. L., Wetter, D. A., & Nguyen, G. H. (2026). Drug Survival of Adalimumab and Infliximab in Hidradenitis Suppurativa. International Journal of Dermatology, 65(9), 1907-1909. https://doi.org/10.1111/ijd.70455
Vancouver
Shrestha R, Tran HTT, Van DL, Wetter DA, Nguyen GH. Drug Survival of Adalimumab and Infliximab in Hidradenitis Suppurativa. International Journal of Dermatology. 2026;65(9):1907-1909. doi:10.1111/ijd.70455
BibTeX
@article{Shrestha2026,
author = {Shrestha, Raslina and Tran, Hue T T and Van, Duc L and Wetter, David A and Nguyen, Giang H},
title = {Drug Survival of Adalimumab and Infliximab in Hidradenitis Suppurativa},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {9},
pages = {1907--1909},
doi = {10.1111/ijd.70455}
}
EUVIMED